[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100518120":3},{"organization":4,"armGroups":7,"interventions":38,"overallOfficials":56,"centralContacts":57,"locations":63,"responsibleParty":546,"collaborators":548,"id":551,"slug":552,"hasResults":553,"nctId":554,"briefTitle":555,"officialTitle":556,"acronym":557,"eligibilityCriteria":558,"healthyVolunteers":553,"sex":559,"minAge":560,"maxAge":56,"enrollmentInfo":561,"targetDuration":56,"studyType":564,"phases":565,"briefSummary":567,"conditions":568,"keywords":576,"overallStatus":66,"whyStopped":56,"lastUpdateSubmitDate":589,"lastUpdatePostDateStruct":590,"startDateStruct":593,"completionDateStruct":595,"leadSponsor":597,"locationsCount":598},{"fullName":5,"class":6},"Kura Oncology, Inc.","INDUSTRY",[8,14,19,24,28,31,34],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm #1: RAS-altered advanced solid tumors, monotherapy (escalation phase)","EXPERIMENTAL","Patients with advanced solid tumors and the following:\n\n* HRAS-mutant and\u002For amplified tumors (any solid tumor type)\n* HRAS overexpression (only for HNSCC tumors)\n* KRAS and\u002For NRAS and\u002For HRAS-mutant and\u002For amplified for NSCLC or CRC\n* KRAS-mutant and\u002For amplified PDAC",[13],"Drug: Darlifarnib",{"label":15,"type":10,"description":16,"interventionNames":17},"Arm #2: Advanced or metastatic RCC, combination therapy (escalation phase)","Patients who have received at least 1 prior systemic therapy with immuno-oncology (IO)-based treatment for locally advanced or metastatic RCC with predominantly clear cell subtype; non-clear cell RCC patients who are either treatment naïve or have received any prior systemic treatment for locally advanced and metastatic RCC",[13,18],"Drug: Cabozantinib",{"label":20,"type":10,"description":21,"interventionNames":22},"Arm #3: Advanced or metastatic NSCLC, CRC, or PDAC, combination therapy (escalation phase)","Patients with KRAS G12C-mutant locally advanced or metastatic NSCLC, CRC, or PDAC who have received at least 1 prior systemic therapy including available approved standard of care treatments",[13,23],"Drug: Adagrasib",{"label":25,"type":10,"description":26,"interventionNames":27},"Arm #4: Advanced or metastatic ccRCC, combination therapy (expansion phase)","Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC",[13,18],{"label":29,"type":10,"description":26,"interventionNames":30},"Arm #5: Advanced or metastatic ccRCC, monotherapy (expansion phase)",[18],{"label":32,"type":10,"description":26,"interventionNames":33},"Arm #6: Advanced or metastatic ccRCC, cabozantinib rollover to combination therapy (expansion phase)",[13,18],{"label":35,"type":10,"description":36,"interventionNames":37},"Arm #7: Advanced or metastatic NSCLC, combination therapy (expansion phase)","Patients with KRAS G12C-mutant locally advanced or metastatic NSCLC who have received at least 1 prior systemic therapy including available approved standard of care treatments",[13,23],[39,46,51],{"type":40,"name":41,"description":42,"armGroupLabels":43,"otherNames":44},"DRUG","Darlifarnib","Oral administration",[9,15,20,25,32,35],[45],"KO-2806",{"type":40,"name":47,"description":42,"armGroupLabels":48,"otherNames":49},"Cabozantinib",[15,25,29,32],[50],"Cabometyx",{"type":40,"name":52,"description":42,"armGroupLabels":53,"otherNames":54},"Adagrasib",[20,35],[55],"Krazati",null,[58],{"name":59,"role":60,"phone":61,"phoneExt":56,"email":62},"Kura Medical Information","CONTACT","844-KURAONC (844-587-2662)","medinfo@kuraoncology.com",[64,78,87,102,113,125,139,153,161,174,188,202,217,226,241,256,266,282,296,309,323,337,352,363,376,389,398,409,418,427,445,458,467,476,489,504,517,533],{"facility":65,"status":66,"city":67,"state":68,"zip":69,"country":70,"countryCode":71,"cosmosGeoPoint":72,"geoPoint":77,"contacts":56},"Mayo Clinic Comprehensive Cancer Center","RECRUITING","Phoenix","Arizona","85054","United States","US",{"type":73,"coordinates":74},"Point",[75,76],-112.07404,33.44838,{"lat":76,"lon":75},{"facility":79,"status":66,"city":80,"state":68,"zip":81,"country":70,"countryCode":71,"cosmosGeoPoint":82,"geoPoint":86,"contacts":56},"University of Arizona","Tucson","85724",{"type":73,"coordinates":83},[84,85],-110.92648,32.22174,{"lat":85,"lon":84},{"facility":88,"status":66,"city":89,"state":90,"zip":91,"country":70,"countryCode":71,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"University of Southern California","Los Angeles","California","90033",{"type":73,"coordinates":93},[94,95],-118.24368,34.05223,{"lat":95,"lon":94},[98],{"name":99,"role":60,"phone":100,"phoneExt":56,"email":101},"Xiomara Menendez, RN","323-865-3000","Xiomara.Menendez@med.usc.edu",{"facility":103,"status":66,"city":89,"state":90,"zip":104,"country":70,"countryCode":71,"cosmosGeoPoint":105,"geoPoint":107,"contacts":108},"Cedars-Sinai Medical Center","90048",{"type":73,"coordinates":106},[94,95],{"lat":95,"lon":94},[109],{"name":110,"role":60,"phone":111,"phoneExt":56,"email":112},"William Mills","310-423-0102","william.mills@cshs.org",{"facility":114,"status":66,"city":89,"state":90,"zip":115,"country":70,"countryCode":71,"cosmosGeoPoint":116,"geoPoint":118,"contacts":119},"UCLA Department of Medicine","90095",{"type":73,"coordinates":117},[94,95],{"lat":95,"lon":94},[120],{"name":121,"role":60,"phone":122,"phoneExt":123,"email":124},"Christopher Lim","310-633-8400","16043","christopherlim@mednet.ucla.edu",{"facility":126,"status":66,"city":127,"state":128,"zip":129,"country":70,"countryCode":71,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Sarah Cannon Research Institute at HealthONE","Denver","Colorado","80218",{"type":73,"coordinates":131},[132,133],-104.9847,39.73915,{"lat":133,"lon":132},[136],{"name":56,"role":60,"phone":137,"phoneExt":56,"email":138},"720-754-2610","CANN.DDUDenverGeneral@sarahcannon.com",{"facility":140,"status":66,"city":141,"state":142,"zip":143,"country":70,"countryCode":71,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"AdventHealth Celebration","Celebration","Florida","34747",{"type":73,"coordinates":145},[146,147],-81.53313,28.32529,{"lat":147,"lon":146},[150],{"name":151,"role":60,"phone":56,"phoneExt":56,"email":152},"Amy Whitaker","amy.whitaker@adventhealth.com",{"facility":65,"status":66,"city":154,"state":142,"zip":155,"country":70,"countryCode":71,"cosmosGeoPoint":156,"geoPoint":160,"contacts":56},"Jacksonville","32224",{"type":73,"coordinates":157},[158,159],-81.65565,30.33218,{"lat":159,"lon":158},{"facility":162,"status":66,"city":163,"state":142,"zip":164,"country":70,"countryCode":71,"cosmosGeoPoint":165,"geoPoint":169,"contacts":170},"Florida Cancer Specialists","Sarasota","34232",{"type":73,"coordinates":166},[167,168],-82.53065,27.33643,{"lat":168,"lon":167},[171],{"name":172,"role":60,"phone":56,"phoneExt":56,"email":173},"Nancy Olsen","nolsen@flcancer.com",{"facility":175,"status":66,"city":176,"state":177,"zip":178,"country":70,"countryCode":71,"cosmosGeoPoint":179,"geoPoint":183,"contacts":184},"University of Iowa Hospitals & Clinics","Iowa City","Iowa","52242",{"type":73,"coordinates":180},[181,182],-91.53017,41.66113,{"lat":182,"lon":181},[185],{"name":186,"role":60,"phone":187,"phoneExt":56,"email":56},"Mimi McKay","319-353-8155",{"facility":189,"status":66,"city":190,"state":191,"zip":192,"country":70,"countryCode":71,"cosmosGeoPoint":193,"geoPoint":197,"contacts":198},"Dana-Farber Cancer Institute","Boston","Massachusetts","02215",{"type":73,"coordinates":194},[195,196],-71.05977,42.35843,{"lat":196,"lon":195},[199],{"name":200,"role":60,"phone":56,"phoneExt":56,"email":201},"Kailene Sullivan, RN","kailene_sullivan@dfci.harvard.edu",{"facility":203,"status":66,"city":204,"state":205,"zip":206,"country":70,"countryCode":71,"cosmosGeoPoint":207,"geoPoint":211,"contacts":212},"Henry Ford Health System","Detroit","Michigan","48202",{"type":73,"coordinates":208},[209,210],-83.04575,42.33143,{"lat":210,"lon":209},[213],{"name":214,"role":60,"phone":215,"phoneExt":56,"email":216},"Bethany Adams, RN","248-224-7345","badams19@HFHS.ORG",{"facility":65,"status":66,"city":218,"state":219,"zip":220,"country":70,"countryCode":71,"cosmosGeoPoint":221,"geoPoint":225,"contacts":56},"Rochester","Minnesota","55905",{"type":73,"coordinates":222},[223,224],-92.4699,44.02163,{"lat":224,"lon":223},{"facility":227,"status":66,"city":228,"state":229,"zip":230,"country":70,"countryCode":71,"cosmosGeoPoint":231,"geoPoint":235,"contacts":236},"Washington University School of Medicine","St Louis","Missouri","63110",{"type":73,"coordinates":232},[233,234],-90.19789,38.62727,{"lat":234,"lon":233},[237],{"name":238,"role":60,"phone":239,"phoneExt":56,"email":240},"Jessica Ley","314-747-8092","jcley@wustl.edu",{"facility":242,"status":66,"city":243,"state":244,"zip":245,"country":70,"countryCode":71,"cosmosGeoPoint":246,"geoPoint":250,"contacts":251},"Rutgers Cancer Institute of New Jersey","New Brunswick","New Jersey","08901",{"type":73,"coordinates":247},[248,249],-74.45182,40.48622,{"lat":249,"lon":248},[252],{"name":253,"role":60,"phone":254,"phoneExt":56,"email":255},"Mohammad Ghalib","718-405-8515","mhg68@cinj.rutgers.edu",{"facility":257,"status":66,"city":258,"state":259,"zip":260,"country":70,"countryCode":71,"cosmosGeoPoint":261,"geoPoint":265,"contacts":56},"Ohio State University","Columbus","Ohio","43210",{"type":73,"coordinates":262},[263,264],-82.99879,39.96118,{"lat":264,"lon":263},{"facility":267,"status":66,"city":268,"state":269,"zip":270,"country":70,"countryCode":71,"cosmosGeoPoint":271,"geoPoint":275,"contacts":276},"OU Stephenson Cancer Center","Oklahoma City","Oklahoma","73104",{"type":73,"coordinates":272},[273,274],-97.51643,35.46756,{"lat":274,"lon":273},[277],{"name":278,"role":60,"phone":279,"phoneExt":280,"email":281},"Christina Caldwell","405-271-8001","48171","Christina-Caldwell@ouhsc.edu",{"facility":283,"status":66,"city":284,"state":285,"zip":286,"country":70,"countryCode":71,"cosmosGeoPoint":287,"geoPoint":291,"contacts":292},"UPMC Hillman Cancer Center","Pittsburgh","Pennsylvania","15232",{"type":73,"coordinates":288},[289,290],-79.99589,40.44062,{"lat":290,"lon":289},[293],{"name":294,"role":60,"phone":56,"phoneExt":56,"email":295},"Immunotherapy and Drug Development Center (IDDC) Referrals","ClinicalResearchServicesHCCIDDC@upmc.edu",{"facility":297,"status":66,"city":298,"state":299,"zip":300,"country":70,"countryCode":71,"cosmosGeoPoint":301,"geoPoint":305,"contacts":306},"SCRI - Oncology Partners","Nashville","Tennessee","37203",{"type":73,"coordinates":302},[303,304],-86.78444,36.16589,{"lat":304,"lon":303},[307],{"name":56,"role":60,"phone":308,"phoneExt":56,"email":56},"844-482-4812",{"facility":310,"status":66,"city":311,"state":312,"zip":313,"country":70,"countryCode":71,"cosmosGeoPoint":314,"geoPoint":318,"contacts":319},"UT Southwestern Simmons Cancer Center","Dallas","Texas","75235",{"type":73,"coordinates":315},[316,317],-96.80667,32.78306,{"lat":317,"lon":316},[320],{"name":321,"role":60,"phone":56,"phoneExt":56,"email":322},"Tian Zhang, MD","Tian.Zhang@utsouthwestern.edu",{"facility":324,"status":66,"city":325,"state":312,"zip":326,"country":70,"countryCode":71,"cosmosGeoPoint":327,"geoPoint":331,"contacts":332},"MD Anderson Cancer Center","Houston","77030",{"type":73,"coordinates":328},[329,330],-95.36327,29.76328,{"lat":330,"lon":329},[333],{"name":334,"role":60,"phone":335,"phoneExt":56,"email":336},"Ly M Nguyen","(832) 794-3672","lmnguyen1@mdanderson.org",{"facility":338,"status":66,"city":339,"state":340,"zip":341,"country":70,"countryCode":71,"cosmosGeoPoint":342,"geoPoint":346,"contacts":347},"University of Wisconsin (Carbone Cancer Center)","Madison","Wisconsin","53792",{"type":73,"coordinates":343},[344,345],-89.40123,43.07305,{"lat":345,"lon":344},[348],{"name":349,"role":60,"phone":350,"phoneExt":56,"email":351},"UW Carbone Cancer Center - Cancer Connect","800-622-8922","clinicaltrials@cancer.wisc.edu",{"facility":353,"status":66,"city":354,"state":56,"zip":355,"country":356,"countryCode":357,"cosmosGeoPoint":358,"geoPoint":362,"contacts":56},"Centre Leon Berard","Lyon","69495","France","FR",{"type":73,"coordinates":359},[360,361],4.84789,45.74906,{"lat":361,"lon":360},{"facility":364,"status":66,"city":365,"state":56,"zip":366,"country":356,"countryCode":357,"cosmosGeoPoint":367,"geoPoint":371,"contacts":372},"Oncologie médicale - Pitié-Salpêtrière","Paris","75013",{"type":73,"coordinates":368},[369,370],2.3488,48.85341,{"lat":370,"lon":369},[373],{"name":374,"role":60,"phone":56,"phoneExt":56,"email":375},"Marianne Veyri","marianne.veyri@aphp.fr",{"facility":377,"status":66,"city":365,"state":56,"zip":378,"country":356,"countryCode":357,"cosmosGeoPoint":379,"geoPoint":381,"contacts":382},"Hopital Européen Georges Pompidou","75015",{"type":73,"coordinates":380},[369,370],{"lat":370,"lon":369},[383,386],{"name":384,"role":60,"phone":56,"phoneExt":56,"email":385},"Anna Farran","anna.farran@aphp.fr",{"name":387,"role":60,"phone":56,"phoneExt":56,"email":388},"Clémentine Drain","clementine.drain@aphp.fr",{"facility":390,"status":66,"city":391,"state":56,"zip":392,"country":356,"countryCode":357,"cosmosGeoPoint":393,"geoPoint":397,"contacts":56},"Institut Universitaire du Cancer Toulouse - Oncopole","Toulouse","31059",{"type":73,"coordinates":394},[395,396],1.44367,43.60426,{"lat":396,"lon":395},{"facility":399,"status":66,"city":400,"state":56,"zip":401,"country":402,"countryCode":403,"cosmosGeoPoint":404,"geoPoint":408,"contacts":56},"Charité - Universitätsmedizin Berlin","Berlin","12203","Germany","DE",{"type":73,"coordinates":405},[406,407],13.41053,52.52437,{"lat":407,"lon":406},{"facility":410,"status":66,"city":411,"state":56,"zip":412,"country":402,"countryCode":403,"cosmosGeoPoint":413,"geoPoint":417,"contacts":56},"Universitätsklinikum Ulm","Ulm","89081",{"type":73,"coordinates":414},[415,416],9.99155,48.39841,{"lat":416,"lon":415},{"facility":419,"status":66,"city":420,"state":56,"zip":421,"country":402,"countryCode":403,"cosmosGeoPoint":422,"geoPoint":426,"contacts":56},"Universitätsklinikum Würzburg","Würzburg","97080",{"type":73,"coordinates":423},[424,425],9.95121,49.79391,{"lat":425,"lon":424},{"facility":428,"status":66,"city":429,"state":56,"zip":430,"country":431,"countryCode":432,"cosmosGeoPoint":433,"geoPoint":437,"contacts":438},"Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS","Bologna","40138","Italy","IT",{"type":73,"coordinates":434},[435,436],11.33875,44.49381,{"lat":436,"lon":435},[439,442],{"name":440,"role":60,"phone":56,"phoneExt":56,"email":441},"Serena Aloi","serena.aloi@aosp.bo.it",{"name":443,"role":60,"phone":56,"phoneExt":56,"email":444},"Mirela Giordano","mirela.giordano@aosp.bo.it",{"facility":446,"status":66,"city":447,"state":56,"zip":448,"country":431,"countryCode":432,"cosmosGeoPoint":449,"geoPoint":453,"contacts":454},"Fondazione Piemonte per l'Oncologia - IRCCs Candiolo","Candiolo","10060",{"type":73,"coordinates":450},[451,452],7.59812,44.95858,{"lat":452,"lon":451},[455],{"name":456,"role":60,"phone":56,"phoneExt":56,"email":457},"Vanesa Gregorc, MD","Vanesa.gregorc@ircc.it",{"facility":459,"status":66,"city":460,"state":56,"zip":461,"country":431,"countryCode":432,"cosmosGeoPoint":462,"geoPoint":466,"contacts":56},"Istituto Nazionale Tumori IRCCS","Naples","80131",{"type":73,"coordinates":463},[464,465],14.26811,40.85216,{"lat":465,"lon":464},{"facility":468,"status":66,"city":469,"state":56,"zip":470,"country":431,"countryCode":432,"cosmosGeoPoint":471,"geoPoint":475,"contacts":56},"Humanitas University","Rozzano","20089",{"type":73,"coordinates":472},[473,474],9.1559,45.38193,{"lat":474,"lon":473},{"facility":477,"status":66,"city":478,"state":56,"zip":479,"country":431,"countryCode":432,"cosmosGeoPoint":480,"geoPoint":484,"contacts":485},"AOU Verona - Centro Ricerche Cliniche di Verona","Verona","37134",{"type":73,"coordinates":481},[482,483],10.9938,45.43854,{"lat":483,"lon":482},[486],{"name":487,"role":60,"phone":56,"phoneExt":56,"email":488},"Andrea Zivi, MD","andrea.zivi@aovr.veneto.it",{"facility":490,"status":66,"city":491,"state":56,"zip":492,"country":493,"countryCode":494,"cosmosGeoPoint":495,"geoPoint":499,"contacts":500},"Hospital Universitari Vall d'Hebron","Barcelona","08035","Spain","ES",{"type":73,"coordinates":496},[497,498],2.15899,41.38879,{"lat":498,"lon":497},[501],{"name":502,"role":60,"phone":56,"phoneExt":56,"email":503},"Paula Barranco","paulabarranco@vhio.net",{"facility":505,"status":66,"city":491,"state":56,"zip":506,"country":493,"countryCode":494,"cosmosGeoPoint":507,"geoPoint":509,"contacts":510},"Hospital de la Santa Creu i de Sant Pau","08041",{"type":73,"coordinates":508},[497,498],{"lat":498,"lon":497},[511,514],{"name":512,"role":60,"phone":56,"phoneExt":56,"email":513},"Mireia Llobet Busquets","mllobetb@santpau.cat",{"name":515,"role":60,"phone":56,"phoneExt":56,"email":516},"Phase 1 Center","IR_fases1onco@santpau.cat",{"facility":518,"status":66,"city":519,"state":56,"zip":520,"country":493,"countryCode":494,"cosmosGeoPoint":521,"geoPoint":525,"contacts":526},"Hospital HM Sanchinarro START Madrid-CIOCC","Madrid","28050",{"type":73,"coordinates":522},[523,524],-3.70256,40.4165,{"lat":524,"lon":523},[527,530],{"name":528,"role":60,"phone":56,"phoneExt":56,"email":529},"Maria Garrido, RN","maria.garrido@startmadrid.com",{"name":531,"role":60,"phone":56,"phoneExt":56,"email":532},"Esther Ordoñez","esther.ordonez@startmadrid.com",{"facility":534,"status":66,"city":535,"state":56,"zip":536,"country":493,"countryCode":494,"cosmosGeoPoint":537,"geoPoint":541,"contacts":542},"Hospital Universitario Virgen del Rocío","Seville","41013",{"type":73,"coordinates":538},[539,540],-5.97317,37.38283,{"lat":540,"lon":539},[543],{"name":544,"role":60,"phone":56,"phoneExt":56,"email":545},"Rosa María Ballesteros","rballesteros.oncologiahuvr@gmail.com",{"type":547,"investigatorFullName":56,"investigatorTitle":56,"investigatorAffiliation":56,"oldNameTitle":56,"oldOrganization":56},"SPONSOR",[549],{"name":550,"class":6},"Mirati Therapeutics Inc.","100518120","phase-1-ko-2806-monotherapy-and-combination-therapies-in-advanced-solid-tumors-100518120",false,"NCT06026410","KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors","Phase 1, First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of KO-2806 When Administered as Monotherapy and in Combination Therapy in Adult Patients With Advanced Solid Tumors","FIT-001","Inclusion Criteria:\n\n* At least 18 years of age.\n* Histologically or cytologically confirmed advanced solid tumors\n\n  * Arm #1 (KO-2806 monotherapy): Patients who have progressed on, or are refractory to, standard of care (SOC) treatments with advanced solid tumors, specifically: HRAS-mutant and\u002For amplified tumors (any solid tumor type); HRAS overexpression (only for HNSCC tumors); KRAS and\u002For NRAS, and\u002For HRAS-mutant and\u002For amplified NSCLC or CRC; KRAS-mutant and\u002For amplified PDAC\n  * Arm #2 (Combination): Patients who have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic RCC with predominantly clear cell subtype; non-clear cell RCC patients who are either treatment-naïve or have received any prior systemic treatment for locally advanced and metastatic RCC.\n  * Arm #3 (Combination): Patients who have received at least 1 prior systemic therapy including available approved SOC treatments for KRAS G12C-mutant locally advanced or metastatic NSCLC, CRC, or PDAC.\n  * Arm #4 (Combination): Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC, but no more than 3 prior systemic anticancer therapies.\n  * Arm #5 (Cabozantinib monotherapy): Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC, but no more than 3 prior systemic anticancer therapies.\n  * Arm #6 (Cabozantinib rollover to combination): Patients must be cabozantinib-naïve and have received at least 1 prior systemic therapy with IO-based treatment for locally advanced or metastatic ccRCC, but no more than 3 prior systemic anticancer therapies.\n  * Arm #7 (Combination): Patients who have received at least 1 prior systemic therapy including available approved SOC treatments for KRAS G12C-mutant locally advanced or metastatic NSCLC\n* Measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.\n* Karnofsky Performance Status of 70 or higher with no clinically significant deterioration over the previous 2 weeks.\n* Acceptable liver, renal, endocrine, and hematologic function.\n* Other protocol-defined inclusion criteria may apply.\n\nExclusion Criteria:\n\n* Any use of anticancer therapy within 14 days or 5 half-lives (whichever is shorter) of Cycle 1 Day 1.\n* Prior treatment with an FTI or HRAS inhibitor.\n* Major surgery, other than local procedures, within 28 days prior to Cycle 1 Day 1, without complete recovery.\n* Spinal cord compression, leptomeningeal disease, or clinically active CNS metastases.\n* Toxicity (excluding alopecia) from prior therapy that has not been completely resolved to baseline at the time of consent.\n* Active or prior documented autoimmune or inflammatory disorders within the past 5 years prior to Cycle 1 Day 1 (with exceptions).\n* Active, uncontrolled bacterial, viral, or fungal infections requiring systemic therapy.\n* Inability to swallow, impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of the trial drugs.\n* Inadequate cardiac and\u002For vascular function, including receipt of treatment for unstable angina, myocardial infarction, and\u002For cerebrovascular attack within the prior 6 months, mean QTcF ≥470 ms, or Class II or greater congestive heart failure.\n* Other invasive malignancy within 2 years.\n* Other protocol-defined exclusion criteria may apply.","ALL","18 Years",{"count":562,"type":563},300,"ESTIMATED","INTERVENTIONAL",[566],"PHASE1","This first-in-human (FIH) dose-escalation and dose-validation\u002Fexpansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.",[569,570,571,572,573,574,575],"Solid Tumors With HRAS Alterations","Non Small Cell Lung Cancer (NSCLC)","Colorectal Cancer (CRC)","Pancreatic Ductal Adenocarcinoma (PDAC)","Clear Cell Renal Cell Carcinoma (ccRCC)","Renal Cell Carcinoma (Kidney Cancer)","Non Clear Cell Renal Cell Carcinoma (nccRCC)",[577,578,579,580,581,582,583,584,585,586,587,588],"HRAS","KRAS","NRAS","Farnesyltransferase inhibitor (FTI)","Tyrosine Kinase inhibitor (TKI)","Phase 1","KRAS G12C inhibitor","NSCLC","ccRCC","RCC","PDAC","CRC","2026-06-04",{"date":591,"type":592},"2026-06-08","ACTUAL",{"date":594,"type":592},"2023-10-18",{"date":596,"type":563},"2027-04",{"name":5,"class":6},38]